Involvement of a AS3MT/c‐Fos/p53 signaling axis in arsenic‐induced tumor in human lung cells

Arsenite methyltransferase (AS3MT) is an enzyme that catalyzes the dimethylation of arsenite (+3 oxidation state). At present, the studies on arsenic carcinogenicity mainly focus on studying the polymorphisms of AS3MT and measuring their catalytic activities. We recently showed that AS3MT was overexpressed in lung cancer patients who had not been exposed to arsenic. However, little is known about the molecular mechanisms of AS3MT in arsenite‐induced tumorigenesis. In this study, we showed that AS3MT protein expression was higher in the arsenic‐exposed population compared to the unexposed population. AS3MT was also overexpressed in human lung adenocarcinoma (A549) and human bronchial epithelial (16HBE) cells exposed to arsenic (A549: 20–60 μmol/L; 16HBE: 2–6 μmol/L) for 48 h. Furthermore, we investigated the effects of AS3MT on cell proliferation and apoptosis using siRNA. The downregulation of AS3MT inhibited the proliferation and promoted the apoptosis of cells. Mechanistically, AS3MT was found to specifically bind to c‐Fos, thereby inhibiting the binding of c‐Fos to c‐Jun. Additionally, the siRNA‐mediated knockdown of AS3MT enhanced the phosphorylation of Ser392 in p53 by upregulating p38 MAPK expression. This led to the activation of p53 signaling and the upregulated expression of downstream targets, such as p21, Fas, PUMA, and Bax. Together, these studies revealed that the inorganic arsenic‐mediated upregulation of AS3MT expression directly affected the proliferation and apoptosis of cells, leading to arsenic‐induced toxicity or carcinogenicity.

[1]  Guowei Xu,et al.  Curcumin functions as an anti‐inflammatory and antioxidant agent on arsenic‐induced hepatic and kidney injury by inhibiting MAPKs/NF‐κB and activating Nrf2 pathways , 2021, Environmental toxicology.

[2]  Mingjun Sun,et al.  Long non-coding RNA DICER1-AS1-low expression in arsenic-treated A549 cells inhibits cell proliferation by regulating the cell cycle pathway. , 2021, Environmental toxicology and pharmacology.

[3]  Mengjie Wang,et al.  Inorganic arsenic influences cell apoptosis by regulating the expression of MEG3 gene , 2020, Environmental Geochemistry and Health.

[4]  Mingjun Sun,et al.  Inorganic arsenic‐mediated upregulation of AS3MT promotes proliferation of nonsmall cell lung cancer cells by regulating cell cycle genes , 2020, Environmental toxicology.

[5]  Ye Tian,et al.  MiR-26a inhibits proliferation and apoptosis of uveal melanoma cells via regulating p53/MDM2 pathway. , 2020, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[6]  Mingjun Sun,et al.  Arsenic exposure increased expression of HOTAIR and LincRNA-p21 in vivo and vitro , 2020, Environmental Science and Pollution Research.

[7]  Yuxuan Song,et al.  Effects of Arsenic (+3 oxidation state) Methyltransferase Gene Polymorphisms and Expression on Bladder Cancer: Evidence From A Systematic Review, Meta-analysis and TCGA dataset. , 2020, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  T. Reichert,et al.  p53 inhibits the osteogenic differentiation but does not induce senescence in human dental follicle cells. , 2020, Differentiation; research in biological diversity.

[9]  I. Mahjabeen,et al.  Association of arsenic-related AS3MT gene and antioxidant SOD2 gene expression in industrial workers occupationally exposed to arsenic , 2020, Toxicology and industrial health.

[10]  M. Miyagishi,et al.  Neurogenic differentiation factor 1 promotes colorectal cancer cell proliferation and tumorigenesis by suppressing the p53/p21 axis , 2019, Cancer science.

[11]  V. Golimbet,et al.  Effect of VNTR Polymorphism of the AS3MT Gene and Obstetrical Complications on the Severity of Schizophrenia , 2019, Bulletin of Experimental Biology and Medicine.

[12]  P. Boffetta,et al.  Dose-response for assessing the cancer risk of inorganic arsenic in drinking water: the scientific basis for use of a threshold approach , 2019, Critical reviews in toxicology.

[13]  P. Tchounwou,et al.  State of the science review of the health effects of inorganic arsenic: Perspectives for future research , 2018, Environmental toxicology.

[14]  Yi Guo,et al.  miRNA-182-5p, via HIF2α, contributes to arsenic carcinogenesis: evidence from human renal epithelial cells. , 2018, Metallomics : integrated biometal science.

[15]  Y. Hsueh,et al.  Polymorphisms of Arsenic (+3 Oxidation State) Methyltransferase and Arsenic Methylation Capacity Affect the Risk of Bladder Cancer , 2018, Toxicological sciences : an official journal of the Society of Toxicology.

[16]  Binggan Wei,et al.  An investigation of the health effects caused by exposure to arsenic from drinking water and coal combustion: arsenic exposure and metabolism , 2017, Environmental Science and Pollution Research.

[17]  D. Sivakumar,et al.  Identification of 2,4‐dihydroxy‐5‐pyrimidinyl imidothiocarbomate as a novel inhibitor to Y box binding protein‐1 (YB‐1) and its therapeutic actions against breast cancer , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[18]  K. Song,et al.  Case–control study of chronic low‐level exposure of inorganic arsenic species and non‐melanoma skin cancer , 2017, The Journal of dermatology.

[19]  C. Skibola,et al.  Associations between arsenic (+3 oxidation state) methyltransferase (AS3MT) and N‐6 adenine‐specific DNA methyltransferase 1 (N6AMT1) polymorphisms, arsenic metabolism, and cancer risk in a chilean population , 2017, Environmental and molecular mutagenesis.

[20]  Qizhan Liu,et al.  Circ100284, via miR-217 regulation of EZH2, is involved in the arsenite-accelerated cell cycle of human keratinocytes in carcinogenesis. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[21]  Binggan Wei,et al.  Associations of arsenic metabolites, methylation capacity, and skin lesions caused by chronic exposure to high arsenic in tube well water , 2017, Environmental toxicology.

[22]  Jin-Ming Gao,et al.  A new semisynthetic 1-O-acetyl-6-O-lauroylbritannilactone induces apoptosis of human laryngocarcinoma cells through p53-dependent pathway. , 2016, Toxicology in Vitro.

[23]  Ansar Karimian,et al.  Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. , 2016, DNA repair.

[24]  D. Meek.  Regulation of the p53 response and its relationship to cancer. , 2015, The Biochemical journal.

[25]  S. Fox,et al.  Targeting Mdmx to treat breast cancers with wild-type p53 , 2015, Cell Death and Disease.

[26]  Jie Zheng,et al.  Arsenic trioxide inhibits cell proliferation and human papillomavirus oncogene expression in cervical cancer cells. , 2014, Biochemical and biophysical research communications.

[27]  Guifan Sun,et al.  Differences of Urinary Arsenic Metabolites and Methylation Capacity between Individuals with and without Skin Lesions in Inner Mongolia, Northern China , 2014, International journal of environmental research and public health.

[28]  E. Guallar,et al.  Differential methylation of the arsenic (III) methyltransferase promoter according to arsenic exposure , 2014, Archives of Toxicology.

[29]  J. Larner,et al.  T-Type Ca2+ Channel Inhibition Induces p53-Dependent Cell Growth Arrest and Apoptosis through Activation of p38-MAPK in Colon Cancer Cells , 2013, Molecular Cancer Research.

[30]  M. Díaz-Flores,et al.  High glucose induces mitochondrial p53 phosphorylation by p38 MAPK in pancreatic RINm5F cells , 2013, Molecular Biology Reports.

[31]  Jianping Zhang,et al.  Opposed arsenite-mediated regulation of p53-survivin is involved in neoplastic transformation, DNA damage, or apoptosis in human keratinocytes. , 2012, Toxicology.

[32]  E. Guallar,et al.  Arsenic Exposure and Cardiovascular Disease:An Updated Systematic Review , 2012, Current Atherosclerosis Reports.

[33]  Weihua Wen,et al.  Metabolites of arsenic and increased DNA damage of p53 gene in arsenic plant workers. , 2011, Toxicology and applied pharmacology.

[34]  D. Givol,et al.  Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells , 2010, Oncogene.

[35]  S. Koo,et al.  AMY2A: a possible tumor-suppressor gene of 1p21.1 loss in gastric carcinoma. , 2010, International journal of oncology.

[36]  K. Wiman,et al.  Regulation of tumor suppressor p53 at the RNA level , 2010, Journal of Molecular Medicine.

[37]  Joana M. Xavier,et al.  The role of p53 in apoptosis. , 2010, Discovery medicine.

[38]  Y. Miki,et al.  DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter. , 2009, The Biochemical journal.

[39]  C. Tseng.  A review on environmental factors regulating arsenic methylation in humans. , 2009, Toxicology and applied pharmacology.

[40]  L. Barraj,et al.  Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis. , 2008, Regulatory toxicology and pharmacology : RTP.

[41]  A. Zhang,et al.  Unventilated Indoor Coal-Fired Stoves in Guizhou Province, China: Cellular and Genetic Damage in Villagers Exposed to Arsenic in Food and Air , 2007, Environmental health perspectives.

[42]  M. Stýblo,et al.  shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells. , 2006, Chemical research in toxicology.

[43]  Y. Hsueh,et al.  Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in Taiwan. , 2004, JAMA.

[44]  M. Karin,et al.  AP-1 in cell proliferation and survival , 2001, Oncogene.

[45]  Y Taya,et al.  A role for ATR in the DNA damage-induced phosphorylation of p53. , 1999, Genes & development.

[46]  C. Hassler,et al.  Is arsenic biotransformation a detoxification mechanism for microorganisms? , 2014, Aquatic toxicology.

[47]  Kristin E. Porter,et al.  Individual Differences in Arsenic Metabolism and Lung Cancer in a Case-control Study in Cordoba, Argentina , 2022 .